Aeromics Inc.

Aeromics is developing new small molecule therapeutics, exploiting a novel target for the treatment of CNS edema. The company will exploit the founders’ expertise in the biological control of water and gas permeation in pathological and normal tissues.


Grants, Broadview Ventures, Connecticut Innovations, Minerva Bridge, Angels and Archangels

Hello. Add your message here.